Her-2/neu as Predictive Marker for Endocrine Therapy and Chemotherapy in Patients with Metastatic Breast Cancer

By Köstler Wolfgang J.   Zielinski Christoph C.  

Breast Cancer Research and Treatment, Vol. 81, Iss. 1, 2003-01 ,pp. : 73-84

Springer Publishing Company

Access to resources Recommend Favorite

Women prefer adjuvant endocrine therapy to chemotherapy for breast cancer treatment

By Niikura Naoki  

Breast Cancer, Vol. 20, Iss. 1, 2013-01 ,pp. : 67-74

Springer Publishing Company

Access to resources Recommend Favorite

Resistance to endocrine therapy in breast cancer

By Kurebayashi Junichi  

Cancer Chemotherapy and Pharmacology, Vol. 56, Iss. 1, 2005-11 ,pp. : 39-46

Springer Publishing Company

Access to resources Recommend Favorite

Recovery of menstruation after long-term chemotherapy and endocrine therapy in pre-menopausal patients with breast cancer

By Sakurai Kenichi   Enomoto Katsuhisa   Amano Sadao  

Journal of Cancer Research and Clinical Oncology, Vol. 137, Iss. 4, 2011-04 ,pp. : 615-620

Springer Publishing Company

Access to resources Recommend Favorite

Chemotherapy For Metastatic Breast Cancer--When is Enough Enough?

By Stockler M.   Wilcken N.   Coates A.  

European Journal of Cancer, Vol. 33, Iss. 13, 1997-11 ,pp. : 2147-2148

Elsevier

Access to resources Recommend Favorite